These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3334552)

  • 21. [Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
    Kalai S; Jouaihia W; Mahjoubi F; Ghozzi R; Thabet L; Ben Rejeb S; Hammami A; Kechrid A; Ben Hassen A
    Tunis Med; 2004 Dec; 82(12):1070-4. PubMed ID: 15822507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the Malthus Microbial Growth Analyser to study the post antibiotic effect of antibiotics.
    Gould IM; Jason AC; Milne K
    J Antimicrob Chemother; 1989 Oct; 24(4):523-31. PubMed ID: 2515188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of multiple antibiotic-resistant Gram-negative bacteria on bagged, ready-to-eat baby spinach.
    Walia S; Rana SW; Maue D; Rana J; Kumar A; Walia SK
    Int J Environ Health Res; 2013; 23(2):108-18. PubMed ID: 22838727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of ciprofloxacin, norfloxacin, and ofloxacin against multi-resistant Enterobacteriaceae.
    Niculescu E; Wagener H
    Chemioterapia; 1987 Jun; 6(2 Suppl):132-3. PubMed ID: 3509369
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of the new beta lactams in severe infections. Imipenem and aztreonam: indications and limitations].
    Sánchez C; Garau J
    Enferm Infecc Microbiol Clin; 1989; 7 Suppl 1():67-75. PubMed ID: 2490491
    [No Abstract]   [Full Text] [Related]  

  • 26. Instability of in vitro resistance to imipenem in Pseudomonas aeruginosa.
    Wolter EJ; Witte W
    J Basic Microbiol; 1990; 30(8):617-22. PubMed ID: 2129043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Belgian multicenter study on the in vitro activity of aztreonam against gram-negative bacilli.
    Verbist L; Van der Auwera P
    Acta Clin Belg; 1988; 43(1):19-26. PubMed ID: 3284263
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of ceftazidime, amikacin and ciprofloxacin on biofilm formation by some enterobacterial clinical isolates.
    Bret L; Di Martino P
    Chemotherapy; 2004 Nov; 50(5):255-9. PubMed ID: 15528892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical resistance to ceftazidime and aztreonam in Proteus mirabilis.
    Salauze B; Petit JC
    J Antimicrob Chemother; 1989 Mar; 23(3):454-5. PubMed ID: 2659567
    [No Abstract]   [Full Text] [Related]  

  • 30. The in-vitro activity of SQ 82,291, a new monobactam, in comparison with aztreonam.
    García-Rodríguez JA; García-Sánchez JE; Plata A; Trujillano I
    J Antimicrob Chemother; 1986 Mar; 17(3):303-7. PubMed ID: 3754552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):57-60. PubMed ID: 7789099
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
    Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
    Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
    [No Abstract]   [Full Text] [Related]  

  • 33. Imipenem and aztreonam: current role in antimicrobial therapy.
    Rice LB; Eliopoulos GM
    Curr Clin Top Infect Dis; 1989; 10():109-39. PubMed ID: 2679691
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of aztreonam and imipenem induction of class I beta-lactamase in Enterobacter cloacae ATCC 13047.
    Gatus BJ; Bell SM; Jimenez AS
    J Antimicrob Chemother; 1989 Dec; 24(6):841-9. PubMed ID: 2621176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli.
    Simon DM; Koenig G; Trenholme GM
    J Infect Dis; 1991 Oct; 164(4):800-2. PubMed ID: 1894940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the in vitro antibacterial activity of ciprofloxacin and thirteen other antimicrobial drugs with respect to recently isolated pathogens.
    Maccanti O; Cosci S; Bonadio M
    J Chemother; 1990 Feb; 2(1):31-6. PubMed ID: 2332781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral administration of antimicrobial drugs can affect the intestinal microflora of rat.
    Benini A; Bertazzoni Minelli E
    Pharmacol Res; 1992; 25 Suppl 1():75-6. PubMed ID: 1387213
    [No Abstract]   [Full Text] [Related]  

  • 38. Microbial resistance to ciprofloxacin.
    Tullio CJ
    Am J Hosp Pharm; 1992 Jan; 49(1):73. PubMed ID: 1570869
    [No Abstract]   [Full Text] [Related]  

  • 39. In-vitro antibacterial activity of SQ 26,776.
    Norrby R; Friberg K; Holm SE
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():69-76. PubMed ID: 7199045
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasmid-mediated ceftazidime resistance.
    Drabu YJ; Blakemore PH; Cox DM; McLaren A
    J Antimicrob Chemother; 1989 Feb; 23(2):287-90. PubMed ID: 2651380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.